Potent suppression of HIV-1 cell attachment by Kudzu root extract

Area of Science:

• Phytochemistry
• Virology
• Immunology

Background:

• Current antiretroviral therapy for HIV is limited by cost, side effects, and drug resistance.
• Kudzu (Pueraria lobata) root extract, used in traditional Chinese medicine, contains isoflavones and saponins.
• There is a need for novel therapeutic strategies to combat HIV infection.

Purpose of the Study:

• To investigate the potential of Kudzu root extract as an antiretroviral agent against HIV-1.
• To determine the mechanism of action and specificity of Kudzu's antiviral activity.
• To evaluate Kudzu's efficacy in combination with existing antiretroviral drugs.

Main Methods:

• In vitro studies using cell lines, primary human CD4+ T lymphocytes, and macrophages.
• Assessment of HIV-1 viral entry inhibition.
• Analysis of interaction with viral envelope glycoprotein gp120 and cellular receptors (CD4, CXCR4, CCR5).
• Testing against other viruses (HIV-2, SIV, HCV, Influenza, Zika, Adenovirus) and drug-resistant HIV-1 strains.

Main Results:

• Kudzu root extract significantly inhibited HIV-1 entry into various cell types without causing toxicity.
• The extract blocked the initial attachment of HIV-1 to the cell surface, dependent on gp120 but independent of CD4 and co-receptors.
• Kudzu demonstrated selective activity against lentiviruses (HIV-1, HIV-2, SIV) but not other tested viruses.
• The extract showed synergistic or additive effects with current antiretroviral cocktails and inhibited Enfuvirtide-resistant HIV-1 strains.

Conclusions:

• Kudzu root extract possesses potent antiviral activity against HIV-1 entry.
• Its mechanism involves blocking viral attachment, offering a novel approach to HIV therapy.
• Kudzu root extract may serve as a valuable supplement to existing antiretroviral regimens, potentially overcoming drug resistance.